These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26134485)

  • 1. Site Selective Azo Coupling for Peptide Cyclization and Affinity Labeling of an SH3 Protein.
    Huang F; Nie Y; Ye F; Zhang M; Xia J
    Bioconjug Chem; 2015 Aug; 26(8):1613-22. PubMed ID: 26134485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
    Santamaria F; Wu Z; Boulègue C; Pál G; Lu W
    J Mol Recognit; 2003; 16(3):131-8. PubMed ID: 12833568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azo cyclization: peptide cyclization via azo bridge formation.
    Fridkin G; Gilon C
    J Pept Res; 2002 Aug; 60(2):104-11. PubMed ID: 12102723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 19F NMR studies of solvent exposure and peptide binding to an SH3 domain.
    Evanics F; Kitevski JL; Bezsonova I; Forman-Kay J; Prosser RS
    Biochim Biophys Acta; 2007 Feb; 1770(2):221-30. PubMed ID: 17182189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why ligand cross-reactivity is high within peptide recognition domain families? A case study on human c-Src SH3 domain.
    He P; Wu W; Wang HD; Liao KL; Zhang W; Lv FL; Yang K
    J Theor Biol; 2014 Jan; 340():30-7. PubMed ID: 24021866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cyclic azo-bridged analogs of gonadotropin-releasing hormone.
    Fridkin G; Rahimipour S; Ben-Aroya N; Kapitkovsky A; Di-Segni S; Rosenberg M; Kustanovich I; Koch Y; Gilon C; Fridkin M
    J Pept Sci; 2006 Feb; 12(2):106-15. PubMed ID: 16059965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH3 domains and drug design: ligands, structure, and biological function.
    Dalgarno DC; Botfield MC; Rickles RJ
    Biopolymers; 1997; 43(5):383-400. PubMed ID: 9566119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
    Yamabhai M; Kay BK
    Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of protein-ligand interactions by photocleavage of a cyclic peptide using phosphatidylinositol 3-kinase SH3 domain as model system.
    Takahashi I; Kuroiwa S; Lindfors HE; Ndamba LA; Hiruma Y; Yajima T; Okishio N; Ubbink M; Hirota S
    J Pept Sci; 2009 Jun; 15(6):411-6. PubMed ID: 19378350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
    Pisabarro MT; Serrano L
    Biochemistry; 1996 Aug; 35(33):10634-40. PubMed ID: 8718852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains.
    Mende F; Beisswenger M; Seitz O
    J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization by capillary counter-diffusion and structure determination of the N114A mutant of the SH3 domain of Abl tyrosine kinase complexed with a high-affinity peptide ligand.
    Cámara-Artigas A; Palencia A; Martínez JC; Luque I; Gavira JA; García-Ruiz JM
    Acta Crystallogr D Biol Crystallogr; 2007 May; 63(Pt 5):646-52. PubMed ID: 17452790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
    Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
    J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.
    Tiwari R; Brown A; Narramaneni S; Sun G; Parang K
    Biochimie; 2010 Sep; 92(9):1153-63. PubMed ID: 20109515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of PxxDY motif recognition in SH3 binding.
    Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
    J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfacial water molecules in SH3 interactions: Getting the full picture on polyproline recognition by protein-protein interaction domains.
    Zafra-Ruano A; Luque I
    FEBS Lett; 2012 Aug; 586(17):2619-30. PubMed ID: 22584053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.